Page last updated: 2024-09-05

aziridine-2-carboxylic acid and Breast Neoplasms

aziridine-2-carboxylic acid has been researched along with Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, H; Ding, C; Ding, Y; Li, D; Liu, Z; Shen, Q; Wang, P; White, MA; Wold, EA; Ye, N; Zhou, J	1

Other Studies

1 other study(ies) available for aziridine-2-carboxylic acid and Breast Neoplasms

Article	Year
Regio- and Stereospecific Synthesis of Oridonin D-Ring Aziridinated Analogues for the Treatment of Triple-Negative Breast Cancer via Mediated Irreversible Covalent Warheads. Journal of medicinal chemistry, 2018, 04-12, Volume: 61, Issue:7 Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Breast; Breast Neoplasms; Catalysis; Cell Line, Tumor; Diterpenes, Kaurane; Drug Discovery; Epithelial Cells; Female; Humans; Mice; Structure-Activity Relationship; Triple Negative Breast Neoplasms; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays	2018

Article

Year

Regio- and Stereospecific Synthesis of Oridonin D-Ring Aziridinated Analogues for the Treatment of Triple-Negative Breast Cancer via Mediated Irreversible Covalent Warheads.

Journal of medicinal chemistry, 2018, 04-12, Volume: 61, Issue:7

Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Breast; Breast Neoplasms; Catalysis; Cell Line, Tumor; Diterpenes, Kaurane; Drug Discovery; Epithelial Cells; Female; Humans; Mice; Structure-Activity Relationship; Triple Negative Breast Neoplasms; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays

2018